Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
10004-cover-webopener.jpg

January 31, 2022 Cover

Volume 100, Issue 4

100 years after insulin was first used to treat type 1 diabetes, researchers are still finding ways to improve it

Cover image:100 years after insulin was first used to treat type 1 diabetes, researchers are still finding ways to improve it

Credit: Will Ludwig/C&EN/University of Toronto/Shutterstock

Full Article
Volume 100 | Issue 4

All Issues

Quote of the Week

“PCSK9 is going to be, I think, the poster child for what modern drug discovery looks like.”

Robert Garbaccio, head of discovery chemistry, Merck & Co.

Insulin’s second century

100 years after insulin was first used to treat type 1 diabetes, researchers are still finding ways to improve it

  • Periodic Graphics: A short history of antiviral drugs

    Chemical educator and Compound Interest blogger Andy Brunning lists some notable compounds that target viruses.

  • COVID-19 lockdowns prevented pollution-related deaths

    Lower emissions during European lockdowns in 2020 could suggest how to improve health in cities longer term

  • Pittcon 2022 is canceled because of COVID-19

    As organizers look at a replacement virtual format, other conferences are going ahead in person

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT